[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"f2c71dea1ae6b193261b97baabbd05af95ed154b513c6ae7e579a7692fdd3145","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"f2c71dea1ae6b193261b97baabbd05af95ed154b513c6ae7e579a7692fdd3145","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"43567f5eb43824827df42553e3002161714f079251cf2ca8ec250f4aae7a2db8","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"43567f5eb43824827df42553e3002161714f079251cf2ca8ec250f4aae7a2db8","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"d0ef79a3a425d61cc5039076903e3e210fffe1a05be02142d4a183ff17fe4011","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"97b2332ccb6664a33e36f2aa94dd3a2083eecb4f8c516b951868202236a47aeb","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"ede0d44741969bd177188783f5feda6a6f40aa8581999c5afcc6493b6099fcb2","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"7ad6c8065ecef9bf94b53f2afb0c5feb1c2de43c13249f4e76170afcbe65e9aa","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"746a6779d87c96586756ce69005099dd6a76ede8638effe7d17df6f07ed149df","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"46ebc774079ff647f6c2a8ad6985789ebe21be88bde06a0ad17657dcad8ce9d8","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"135b4e0c8516b44a24bce106502c2ad4fac6df97295548277453d051d02eec6d","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"64db3fac331acca84f325bd7e4199eddd46f6254d66573063f8e9844f64a3227","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"70504cf01da80bd5ef36c55522b634848e5d8e319c6d7acf8dfd062d8334b731","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"315800e7b4a96db458d32a8a93e191bc2316e5c2228036401a1e15681be3d69d","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"e0122bf7aa166f8b4d2420602114cce5d9f1bd6efa8188caac62560342b69702","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"822d04a699f64126821d63c70a5df913eabbeac77dc6788034544d28c218f518","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"24fc7400719ccb37a75faa80d1a14d83f8f50f20082d96810df20fbc9e7961b6","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"6d024ee2f7ae66ef828be71c46f51e46ec89f725326d8d8a1b1b11bc8a632617","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"180f095a9b4053d48385a3434401a192d7377457f572083ddcaa12320fba63e3","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"8de1fa7ef82354cd689e37a17c5548cc998834670bd76e28ebfddb6049cc51d7","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"854dec5dae150debdb26e4eae9801176233d9f7908eda7531c503181bed998cd","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"736da3ad3b3f31ec29f2ab000706e1a6e5bf7f859c74eb2e5aaafdbc3f36a29c","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"686ba318298c39f29e50f16f51ada349d8c02a2267c4556266912d8704bfb295","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"d5347027f310500db9b6ce2dc224e3285aa0ff39bbe60f940514c3e3a71d5ef4","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"bd0359a4a6365c4573d1b4b901af58b092e64e815786280a02393d889e3db9f9","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"0b2a513b549407d3cd0a2372b206157cce41e336607ada953c050580062e2638","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"f195dc52e248079349f68b80690b8428dd7b97e1f12ee73953abcd7415e7a990","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"63dc121419437541334d69ad94470d0348946e82d5be20a44ae97882a6656d14","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"121c7a66770af0a9c2578a49d6131e7af280911907cf7462d8228a4f8d232ff7","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"855ff47dc07376ad1217a2e3279c58f9c46cb1d8fba1aa0f8958d0916d375ad8","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"97525aeb48c8c213a76a1666888988fc631826a3cdde2f25fb50c95d2d01f7cf","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"b1372128a66b0e566f9dfcce616360b88c1ff2b3081fbc4742b87d2d06dfb286","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"68fcd126650e165d8cee426d3d140bc0ecb6f02415e95e0c5fec843421843ab7","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"957bdb32bd2aec48bb75eda962ed7c85655678541c72fcef01ac16f5b0b4f46b","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"54bc706b53bc9397c1fc0977086a1f750b2bf51ee8203f27285848d4e7899ab8","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"6d1bf0ee0de4f58cc5b50d3ac1a955b403b3b57a812f30ecbdf7a74d2102e99e","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"b4f68d941e7b5841bd19a9c6d2e863b3df07c92f42c99a8423af91038a099348","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"f09498b6c15480a7df220b69487ccfc2de9ba179c47cd312cdfebbd094e52f78","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"4c01a9ae3401fe174829bfea4588160715aeb2e698af76e8419d8fdbcf6c0b76","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"ee3f785ee79be7cb30c7274be0dda3133a775c314e96b23c3cdcc5b8866d1330","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"bf506761035a0807de243740453040b756963960336f36d976171ee41390418e","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"cbdc615d5d94b116fdd24ae4ccedfd667d0a0d157add4d81e1ff5807bc9df448","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"efca02620419532ca364d6f20a22914e4e9f21c4bd8615f40ddc89ca4fbb0ac3","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"f6b630fde5881330c966071b48a7b44aad388eed4816c46edad40c8ad9c8e0c3","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"7789462fed7ca17c415e9798bb7f0206d11dcca277bc3ea992823b1d995188d7","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"5d8e1a28c479e579697f3385f60836bd577e0a660a304286e3a5a92d979b8144","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"6081a76760b8dadaa0d4fd2a4b0ff2938b58b4a16e4c9473e28b5627dbfd3475","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"0cf97b84079d4f7d32e8a267a26c306550033df48505be18e4e8ff99233adb46","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"a86653d12fe5d2da11254c97b4ffdcccbea40a23d599871d61e63c5fa6ca4619","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"5a161fbac9b4744443455461c389e109a7f29ee9541344eb6dfe684749c3bdc8","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"0cf052e9741ade69dc84888cfcfe39c31fb4d7864a66d7670e202f61610b994c","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"01ddcc7402f19ad664e866eac81ff1cf27e40a071ddd7e5eab0614ebafb5ec5d","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"a4e5fb80b75f8b352dda86a4d421091241e83e67b38a3ea977e491e4f8d96c06","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"a3de4b27c2422e4234b2fde7f6ac28bc1fd9969aff7b2d40f3fd981a4e6b030c","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"0b5408391bd3b252848f1b1f00c640923553c6dd049a670e1fef8075a60b86f7","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"2d0d45c1936182452d54d81436a9c0c601bd928d6280e8185d789a8639bdd6bc","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"8acd076efbfbbfa9e5a27dfaf2a246eefa2c8b9830eeaaf1484ac11a3506f080","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"5352fa0dc821cc2069195dd0bc41ee870581465eb61f63ae442fb5aaf1014373","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"6c0f73eee987dbde9c2155591dcd3eb5f9109e35dee1c00039f6745d356f24dd","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"5792c7dd241503bf51a7628008e6afd51f33acab8490f32765bbf5f45dec6cac","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"85760bde33bd495a2e7e8a1598461d927ed6624a5ffb464430de03ef8d62fe64","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"f2ee4384b5632838d8a9c71e516137598d177d518e8ed40296e7a6d361a2a4dc","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"f3cff43817b8f757235fa395d81972c1022eecbab5ebadefb3627a47ef598cc3","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"ca9c03ed79dc3e0d76cbca7b288e64c5cab22a57f66483d40bd46472eb7d33a8","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"3db556f0a90eef741f8e4788cca6f49f377e0edb558abeec298f0498f58fd00c","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"f74e6993f2521cdd7a2ab5fc11e0fd060ffd346e26c96f499bcb875fe876825b","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"6081a76760b8dadaa0d4fd2a4b0ff2938b58b4a16e4c9473e28b5627dbfd3475","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"4a9429752f5f3539f10b1b1b2dcff7937e672def5d663d648c4ed9521edc7ad3","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"921ae9afa53a47fc14f8723d10b8e932b1f6839e23ac6212e11ac6f293adf548","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"db41cdd1c0b896a2697852e8f6860dc7fe2451f4a907a88e513c8cdaee6319b1","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"c1966cf0511afe28e851c4da473b53baffda9ffa7974c834b1937fb62464aca4","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"8f598555548a0516932aa720a16abafe5b447b214a30a508c79e55e1569306b3","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"170ae5ac918bd2832b488dcccb5f4aad16a9af5e204eee9d583922560d8812d0","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"ec48415bbbe3c5b32323a4cfac40d9e6024464810f533fcf399d2aec43133912","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"69b7971440cc820687a1917c1a39dbdf9043774d5afdfee44aec0e9f62febb0b","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"aba567c2bfe74b33e9abaa9fcd714160c9ca3022be527e5db60b87043db9ca3f","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"213db9d9646d55789da08c3ffc42d6aa133ab6c6b7c448eb4bdfd8d4e499db1d","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"08f13433cf6401d145340afad6e61e05dfbaf455014fb345af8282bb4e1638d5","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"9c3337ebce2bd2b01030a843afe74646c374f91438a08268970a029044589d91","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"2a59eb403cd3ca266efe1e0057040f49a333f385164a635c88d0816b499d4cbe","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"74242b1b2d9967ebb9264c2d9fee97e14310f019977c19e3fdf62573ecae078c","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"6cb31fc6c387b20fcf5a58e313d52118488d31903e60c75790687c53bac47242","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"ac02a989e5a9a5fd314171aeafc98100fbaac159eeb789dc342e31af168bf3bb","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"af9dc4e521d153715711490e3c2fa199c5205b24657a8c3bba63de9224c9d6e6","course_number":754,"subjects":["PHMSCI"],"title":"BUSINESS TOOLS FOR PHARMACEUTICAL SCIENTISTS","description":"Explores business aspects of pharmaceutical product development and post-approval product maturation. Covers startup financing, risk management, intellectual property considerations, supply chain management, and strategic decision-making, as applied to both large and small pharmaceutical companies.","requirements_text":"Declared in Pharmaceutical Sciences MS"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"ca9f0ce4ac12d8cfe40e9496a96d54f4962fce18bbeca62983c00178effd0904","course_id":"PHMSCI 754","course_uid":"course_37897e8c1cc993a9a0ae5230","catalog_version_id":"193b764c6f0d13eed251dc6558fca3a3e35c1284cac962529338b328d1efe6af","course_number":754,"subjects":["PHMSCI"],"title":"LIFECYCLE MANAGEMENT OF PHARMACEUTICAL PRODUCTS","description":"Explores the process of bringing pharmaceutical products to market, particularly as it applies to the scaling up, manufacturing, and maintenance phases that come after FDA approval of a product is obtained. Identifies various factors that impact the life cycle management of pharmaceutical products from development to sustained large-scale distribution, such as: target product profile (TPP), chemistry, manufacturing and controls (CMC), active pharmaceutical ingredient (API) supply chain considerations, raw materials shortages, demand planning/forecasting, and post-approval regulatory considerations.","requirements_text":"Declared in MS Pharmaceutical Sciences: Applied Drug Development"}]